中医药通过抑制肿瘤干细胞特性延缓EGFR-TKI耐药的研究进展

Chinese Journal of Cellular and Molecular Immunology ›› 2025, Vol. 41 ›› Issue (01) : 77-82. DOI: 10.13423/j.cnki.cjcmi.009843

Author information +
History +

CLC number

R285

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Comments

Accesses

Citation

Detail
Sections
Recommended
Copyright © Chinese Journal of Cellular and Molecular Immunology, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.

/

〈 〉